SCHEMBL2808240

SCHEMBL2808240

CC(C)(C)c1ccc(-c2c(C(=O)O)n(Cc3cccc(-c4ccc(OCc5ccccc5)cc4)c3)c3ccccc23)cc1

nearest known ligand 0.57

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.57
EDNRB P24530 4/20 0.52
EDNRA P25101 4/20 0.52
PPARG P37231 6/20 0.47
NR4A2 P43354 2/20 0.44
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
NR4A1 P22736 1/20 0.44
NR4A3 Q92570 1/20 0.44
BCL2 P10415 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808138 0.91 SERPINE1 (0.47) SERPINE1EDNRBEDNRAPPARGNR4A2
SCHEMBL2810203 0.90 SERPINE1 (0.62) SERPINE1EDNRBEDNRAPPARG
SCHEMBL2807015 0.88 SERPINE1 (0.62) SERPINE1EDNRBEDNRAPPARGRXRA
SCHEMBL2811200 0.87 SERPINE1 (0.53) SERPINE1EDNRBEDNRAPPARGNR4A2
SCHEMBL2810671 0.85 SERPINE1 (0.59) SERPINE1EDNRBEDNRAPPARG
SCHEMBL2810724 0.85 SERPINE1 (0.64) SERPINE1EDNRBEDNRAPPARG
SCHEMBL8856902 0.84 EDNRB (0.58) SERPINE1EDNRBEDNRANR4A2NR4A1
SCHEMBL2812683 0.83 SERPINE1 (0.51) SERPINE1EDNRBEDNRAPPARGNR4A2
SCHEMBL2811364 0.83 SERPINE1 (0.62) SERPINE1EDNRBEDNRAPPARG
SCHEMBL2806740 0.82 SERPINE1 (0.49) SERPINE1EDNRBEDNRAPPARGNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US claimed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators SMITHKLINE BEECHAM CORPORATION (US) 2010-09-23 US disclosed
EP-2081894-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SmithKline Beecham Corporation (US) 2009-07-29 EP disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed
WO-2008028118-A1 1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES USEFUL AS PPAR MODULATORS SMITHKLINE BEECHAM CORPORAITON (US) 2008-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240642-A1 1H-Indole-2-Carboxylic Acid Derivatives Useful As PPAR Modulators PPARD, PPARA, PPARG SERPINE1 4215/4885EDNRB 452/4885EDNRA 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.